“…Published evidence implicated these 18 genes directly through population studies (GBP6, GSTO1, HHIPL1, INTS10, RGS16 and RNU6-679P), indirectly through association with other metabolic conditions (CCDC69, DNAH2, GALNT17, HERC5, KIF5C, MARCH2 and PRDM14) or through association with complications of T2D (CASC15, CCDC107, MIR147A, PFKFB3 and RNF166). Detailed annotation of the published literature in this regard is provided in Supplementary Table S3 ) [ 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]. From the remaining genes identified to be significantly associated with T2D in this study, there were two open reading frames, three long intergenic non-coding elements and a pseudogene.…”